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AMPLITUDE SPECTRUM AREA AS A PREDICTOR OF SUCCESSFUL 
DEFIBRILLATION: THRESHOLD VALUES ANALYSIS IN A LARGE 
DATABASE OF OUT-OF-HOSPITAL CARDIAC ARREST TREATED BY 
DC-SHOCK 
 
       OVERVIEW 
 
Introduction 
Cardiac arrest represents a dramatic event that can occur suddenly and often 
without warning signs. Cardiopulmonary resuscitation (CPR), including chest compression 
often in conjunction with electrical defibrillation, has the potential to obtain return of 
spontaneous circulation (ROSC). However, CPR is likely to be successful only if it is 
instituted within 5 min after the heart stops beating [1–3]. Ventricular fibrillation (VF) is the 
primary rhythm in many cases of human cardiac arrest, and defibrillation by electric 
countershock represents the treatment of choice for this otherwise lethal arrhythmia. VF 
duration remains a main determinant of countershock success. When the interval between 
estimated VF onset and delivery of the first shock is <5 min, the likelihood is that an 
immediate defibrillation attempt will be successful [4–6]. When the duration of untreated 
VF is >5 min, both human and animal studies demonstrate that initial CPR with chest 
compression prior to delivery of an electrical shock improves the likelihood of ROSC [7–
10]. During cardiac arrest,coronary blood flow ceases, accounting for progressive and 
severe energy imbalance. Intramyocardial hypercarbic acidosis is associated with 
depletion of high-energy phosphates and correspondingly severe global myocardial 
ischaemia [11, 12]. The ischaemic left ventricle (LV) becomes contracted [13], ushering in 
the so-called “stone heart” syndrome [14, 15]. After the  onset of contracture, the 
probability of successful defibrillation is remote. Early CPR that restores coronary 
perfusion pressure (CPP) and myocardial blood flow delays onset of ischaemic myocardial 
injury and facilitates defibrillation [16]. 
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VF is characterised by three time-sensitive electrophysiological phases: (1) the 
electrical phase, of 0–4 min; (2) the circulatory phase, of 4–10 min; (3) the metabolic 
phase, of >10 min. During the electrical phase, in which VF (Type I) waves are mostly of 
high amplitude and more frequent, immediate defibrillation is likely to be successful.   As 
ischaemia progresses, the success of attempted defibrillation diminishes without CPR. 
This phase is characterised by transition to slow VF wavelets during accumulation of 
ischaemic metabolites in the myocardium. Type II VF often fails defibrillation attempts 
because of its re-entry and recurrence due to the loss of capability of restoring the 
electrophysiologic stability within the myocardium. In the metabolic phase, there is no 
likelihood of  successfully restoring a perfusing rhythm [17]. 
More than 50% of all patients initially resuscitated from cardiac arrest 
subsequently die before leaving the hospital [18–20], and the majority of these deaths are 
due to impaired myocardial function [21]. 
The severity of postresuscitation myocardial dysfunction is at least in part related 
to the magnitude of the electrical energy delivered during defibrillation [22, 23]. Increases 
in defibrillation energy are associated with decreased postresuscitation myocardial 
function [22, 24]. It is therefore important to have noninvasive and real-time monitoring that 
predicts whether or not shock will obtain  ROSC. 
Current resuscitation methods are limited  in part by the lack of practical and 
reliable real-time monitoring of the efficacy of CPR interventions and timing for the 
defibrillation attempt. Electrocardiographic (ECG) analyses of VF waveforms represent the 
best noninvasive approach to guide intervention priority, namely, chest compression or 
defibrillation 
 
Monitoring Effectiveness of Chest Compression and  Predicting Return of 
Circulation 
The quality of chest compression is a major determinant of successful 
resuscitation [25–27]. Existing and established predictors of good-quality CPR, and 
thereby successful resuscitation, include CPP [16, 28–30] and end-tidal carbon dioxide 
(etCO2) [31, 32].Blood flow generated by chest compression is dependent on the pressure 
gradient between aortic and venous pressures [33]. CPP , defined as the difference 
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between simultaneously measured minimal aortic pressure and right atrial pressure during 
compression diastole [34-37] is significantly correlated with coronary blood flow during 
cardiac  resuscitation and  is recognized as the best single indicator of successful 
defibrillation [30,38,39]. Based on both experimental and clinical observations, ROSC can 
be predicted when CPP is maintained > 15 mmHg during chest compression [30,39,40].   
Resuscitation strategies that increase CPP, including highly effective chest compression 
[41,42] and the use of vasopressors [[43], are reccommended as considered more 
effective in restoring circulation.       
Expired CO2  (etCO2) is determined  by the body’s production of CO2  and the 
relationship between minute ventilation and pulmonary perfusion. When the circulatory 
status is normal, pulmonary perfusion is within the physiologic ranges and etCO2  is 
determined by minute ventilation. During cardiac arrest and CPR cardiac output is usually 
less than one third of normal and pulmonary flow and etCO2  are dramatically reduced. 
etCO2  is therefore an indirect indicator of pulmonary blood flow and cardiac  output 
produced by chest compression [31,32] and has emerged as a valuable tool for 
noninvasive monitoring of the effectiveness and quality of chest compression during CPR 
[31,32,44-46]. When etCO2   is > 10-15mmHg during CPR, there is a greater likelihood of 
successful ROSC [47-51]; however, this measurement technique is not widely available. 
Portable infrared capnometers can be successfully employed in prehospital settings during 
CPR. However, monitoring etCO2 requires endotracheal intubation. Out-of hospital 
endotracheal intubation carries both a high failure rate and up to a 30% incidence of 
traumatic injury to the airway [52, 53]. Moreover, epinephrine administration during CPR 
causes a signicant decrease in etCO2 by increasing pulmonary shunting [54], which may 
cause an important misinterpretation when monitoring the effectiveness of resuscitative 
manoeuvres. This is in contrasts with the routine availability of ECG in conjunction with 
external debrillators. 
Attempts to find a better predictor of ROSC have therefore focused on analysing 
ECG features of VF. 
 
Analyses of ECG Features During Ventricular Fibrillation and CPR 
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The search for a reliable indicator of successful defibrillation obtained from 
analysing ECG features began more than 20 years ago. Initial approaches included 
measuring VF amplitude [54] first and frequency later [55]. Subsequently, to increase ECG 
sensitivity and specificity predictors for ROSC, more sophisticated methods of VF 
waveform analyses were introduced and investigated, including wavelet decomposition 
[56], nonlinear dynamics methods [57] and a combination of different ECG parameter 
analyses [58]. 
Earlier investigations using ECG focused on VF wavelet amplitude or voltage as 
a predictor of the likelihood of successful debrillation. VF voltage, or signal amplitude, is 
defined as the maximum peak-to-trough VF amplitude in a given time window of the ECG 
signal [59]. Mean VF voltage is calculated as the average over the chosen time interval. It 
has been established that VF amplitude declines over time and greater amplitudes are 
associated with correspondingly greater debrillation success [54, 60–64]. Several studies 
have shown that this ECG feature reflects vital-organ blood flow and in particular 
myocardial blood  flow and energy metabolism [54, 59, 65–67]. Weaver et al. observed 
that patients in whom VF amplitude was >0.2 mV have a signicantly greater likelihood of 
resresuscitation [54]. VF voltage appeared not only as an ROSC predictor but showed 
utility as an indicator for timing VF duration since collapse. Amplitude measurement, 
however, has the disadvantage of depending on the direction of the main fibrillation vector 
and therefore is subject to a great interindividual variance. VF amplitude might also be 
modified by electrode size, location, thoracic impedance, skin condition and chest 
morphology. 
Subsequently, it was realised that other parameters could be computed using 
Fourier transformation analyses in a selected ECG interval, including VF median 
frequency, peak power frequency, edge frequency and spectral flatness measure. The 
starting point for all these calculations was the power spectrum, defined as the square of 
Fourier amplitudes.  Brown et al. [55, 65] specifically developed this technique to analyse 
VF voltage and frequency to obtain the so-called VF median frequency. VF median 
frequency served as a predictor of electrical debrillation success [55, 68]. In a porcine 
model of VF and CPR, a median frequency of >9.14 Hz had 100% sensitivity and 92% 
specificity in predicting successful defibrillation. Frequency analysis of VF wavelets and, 
specifically, median frequency was also correlated with CPPs in animal models and 
humans and therefore became the preferred ECG feature for use as predictor of CPR 
 6 
outcome [55, 63, 65, 66, 69–73]. In addition, this parameter appeared as a more accurate 
indicator for estimating the duration of untreated VF compared with the earlier VF 
amplitude [65, 71, 74, 75]. To determine the best ECG feature prognosticator, several 
studies focused on the changes and differences of VF waveform features in relationship to 
cardiac arrest pathophysiology. Specifically, investigators focused on the differences 
between VF as a result of ischaemic heart disease, which represents the main cause of 
sudden death, and electrically induced VF, which represents the main experimental model 
employed in laboratories [76, 77]. Indik et al. [78] induced VF in swine in which acute 
myocardial infarction followed left anterior descending coronary artery (LAD) ligation. The 
study revealed that VF spectral features, such as median, mean or dominant frequency 
and bandwidth, were signicantly reduced compared with those derived from electrically 
induced VF [79]. In a different porcine model of ischaemically induced cardiac arrest 
through acute LAD occlusion, Ristagno et al  [80] confirmed lower mean VF frequency in 
comparison with electrically induced VF (Fig. A).  
 
 
Fig. A Ventricular  fibrillation (VF): mean frequency during 5 min of untreated VF. 
Closed circle : VF electrically induced; open circle:  VF ischaemically induced 
 
Although VF features might be different in relationship to the cause of cardiac 
arrest, these Authors observed that those features continuously changed during 
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resuscitative manoeuvres in the ischaemic VF model, as well. In particular, VF amplitude 
and mean frequency increased during chest compression, and such increases were 
representative of successful defibrillation [81, 82]. 
These observations provided evidence that ECG predictors of outcome are at 
least in part correlated to the mechanism by which VF evolves. Of more importance, 
relationships between VF amplitudes, frequencies and successful defibrillation are 
maintained in ischaemically induced VF, confirming the utility of ECG predictors of 
outcome. 
Chest compression performed during CPR, however, interferes with ECG signal 
recording, affecting the extracted parameters and therefore leading to incorrect prediction 
of defibrillation outcomes. On the other hand, although CPR might be interrupted for an 
interval to allow acquisition of reliable parameters, this interruption shortens the period of 
vital myocardial perfusion and yields worse outcome and greater postresuscitation 
myocardial dysfunction [83,84]. Several filters and algorithms to reduce and eliminate ECG 
artefacts and noise due to chest compression or ambient interferences have been 
developed and successfully used [59, 63, 66, 85–87]. Among them, the wavelet-transform 
technique constitutes one of the most promising methods [38, 86]. 
  
Amplitude Spectrum Area (AMSA) as Predictor of Successful Defibrillation 
 
The need for ECG analyses and for predicting successful defibrillation escalated 
after the introduction of automated external defibrillators (AEDs). In 1994, Noc and  Bisera 
[64] began investigating ECG VF waveforms as predictors of successful cardiac 
resuscitation. Initially, they focused on the ECG indicator widely investigated at that time 
and specifically evaluated the possibility of using VF amplitude to predict resuscitability in 
a well-established rodent model of cardiac arrest and CPR. Increases in CPP during 
precordial compression were associated with concomitant increases in VF voltage, and  
greater VF voltages were observed in resuscitated animals. Moreover, greater VF voltages 
after initiation of cardiac resuscitation were associated with increases in myocardial 
creatine phosphate and significant decreases in lactate content. Accordingly, increases in 
VF voltage during cardiac resuscitation reflected increases in myocardial perfusion and 
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favourable changes in myocardial energy metabolism, with consequent greater success of 
cardiopulmonary resuscitation. 
In 1999, the same authors [59] developed  a new method of analysing VF 
waveform, the real predecessor of AMSA, in which mean amplitude and dominant 
frequency were combined. The so-called defibrillation predictor (DP) was calculated by 
ECG signals obtained with lead-2 monitoring and in which artefacts produced during 
precordial compression were removed by digital filtering. The DP was tested in a porcine 
model of cardiac arrest and CPR. Successfully resuscitated animals had significantly 
greater CPP,dominant VF amplitude, mean VF amplitude and dominant VF frequency. No 
animals could be resuscitated if the CPP was <8 mmHg, dominant amplitude was <0.48 
mV, mean amplitude was <0.25 mV or dominant frequency <9.9 Hz independently of the 
duration of untreated VF. However, defibrillation attempts uniformly failed when mean 
amplitude was below the threshold level, even though dominant frequency would have 
predicted otherwise. 
When mean amplitude and dominant frequency were combined, predictability 
was signicantly improved. Defibrillations were uniformly unsuccessful if the combination of 
mean amplitude and dominant frequency did not exceed the threshold values obtained in a  
derivation study.  Mean VF amplitude in combination with mean VF frequency was 
expressed as a numeric score .  Using stepwise multiple regression analysis, they 
identified a single numeric score that was established as a DP and represented by the 
following equation: 
DP = 3.60 – 4.85 mean VF amplitude – 0.06 VF dominant frequency 
This DP served as an objective, noninvasive measurement comparable to CPP 
for predicting successful defibrillation.  The ECG predictor nevertheless served as a 
monitor with which there was essentially total predictability of failed defibrillation attempt. 
However, due to its poor positive predictive value (PPV) to predict only 20% of successful 
defibrillation attempts, the rudimental defibrillator predictor was later replaced by the 
amplitude spectrum area [38,88,89]. 
This ECG-derived parameter was obtained starting from conventional ECG 
scalar limb ECG leads. The frontal-plane lead 2 was used for VF wavelet analyses. ECG 
signal was continously sampled and recorded at 300 mHz and further digitized. 
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The signal was selected to be between 4 and 48 Hz to minimize low frequency 
artifacts produced by precordial compression and to exclude electrical interference of 
ambient noise at frequencies >48 Hz. Peak-to-trough VF amplitudes were obtained, and 
the average was calculated for a specific ECG interval. 
The power spectrum was then obtained by squaring the amplitude of each 
frequency component obtained from the fast-Fourier transform of the ECG signal (Fig.B). 
 
Fig B Representative example of amplitude frequency relationship and area under the 
curve that defines the amplitude spectrum area (AMSA) 
 
 The median frequency represented the frequency at which half of the power of 
the spectrum was above and half below and is represented by the following equation: 
MF = Ó Fi x Pi / Ó Pi   where Fi is the ith frequency component and Pi the 
relative power at Fi. AMSA was then calculated from the resulting amplitude frequency 
spectrum according to the following equation: 
AMSA = Ó Ai x Fi            where Ai is the amplitude at the ith frequency Fi. 
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In an initial investigation, Povoas and Bisera [38] investigated CPP obtained from 
arterial and right atrial pressures and VF mean amplitude, median frequency and AMSA 
obtained from ECG recordings from 55 domestic pigs during CPR. From these 
measurements,threshold values for ROSC were obtained and subsequently validated in 
another ten animals. CPP and mean amplitude each had a PPV of 100% but negative 
predictive value (NPV) of only 44% and 22%, respectively. Median frequency predicted 
successful defibrillation, with a PPV of 75% but an NPV of only 30%. Only AMSA yielded a 
more optimal combination of PPV and NPV: 86% and 85%, respectively. Among the 
results obtained with this new ECG parameter, the high NPV was of special interest 
because it was recognised that AMSA would minimise repetitive and ineffective electrical 
shocks during CPR. 
In the same period, Pernat confirmed those results, demonstrating the capability 
of AMSA to optimise ventricular defibrillation timing [88] in a porcine model of cardiac 
arrest and resuscitation in which  AMSA was highly correlated with CPP levels during 
CPR. The AMSA value of 21 mV-Hz predicted perfusing rhythm restoration with sensitivity 
and specificity >90%. AMSA NPV was 95% and statistically equivalent to that of CPP, 
mean amplitude and median frequency. One year later, the same authors [89] further 
investigated the AMSA ECG signal analysis technique to establish a threshold level that 
would have predicted whether an electrical shock would reverse VF in a porcine model. 
The investigators confirmed that an AMSA value of 21 mV-Hz had an NPV of 96% and a 
PPV of 78%. An AMSA value of.21 mV-Hz predicted perfusing rhythm restoration in seven 
of eight instances, and AMSA of 20 mV-Hz correctly predicted electrical resuscitation 
failure in 24 of 26 instances. It therefore became apparent that AMSA represented a 
method that potentially fulfilled the need for minimising ineffective and detrimental 
defibrillation attempts during resuscitative manoeuvres.  In that investigation, AMSA values 
were displayed in real time for the first time and were continuously updated every 5 sec 
interval during CPR. AMSA was not invalidated by artefacts resulting from precordial 
compression. The progressive increases in AMSA observed before successful 
resuscitation further demonstrated that AMSA had the potential to provide an objective 
guide, offering better CPR quality control. Failure to increase AMSA values to near 
threshold levels prognosticated defibrillation failure. 
The initial empirical trials identified AMSA as representing the area under the 
curve based on amplitude and spectral frequency as a more optimal predictor for guiding 
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the defibrillation attempt. The subsequent validation studies confirmed that AMSA has 
impressively higher specificity and PPV compared with the other predictors, maintaining 
sensitivity, NPV, mean amplitude, and median frequency comparable with CPP. Because 
AMSA was obtained during precordial compression, it fulfilled the other goal of allowing for 
uninterrupted precordial compression during ECG analyses. AMSA was well correlated 
with CPP, which is widely recognised as the gold standard for predicting successful 
defibrillation. Yet CPP was robust only for negative prediction. It is specificity and PPV, 
which are assured by AMSA, which are more likely to minimise adverse effects of 
repetitive high-energy shocks during CPR and the resulting postresuscitation myocardial 
dysfunction. 
In more than 65% of the cardiac arrest events, the usual cause is an underlying 
acute or chronic ischaemic heart disease [90–92]. Accordingly, myocardial ischaemia and 
reperfusion have been involved in the triggering of malignant ventricular dysrhythmias [93, 
94] and both duration and severity of myocardial ischaemia play important roles in causing 
myocardial cell damage [95]. Thus, VF amplitude and especially VF frequencies are 
different in instances of ischaemic heart disease. More recently, Indik et al. [78] confirmed 
these results and, more interestingly, demonstrated that AMSA values did not change 
importantly when VF was induced in hearts with underlying ischaemic diseases. During 
CPR, however, Ristagno et al proved that reduced coronary blood flow significantly affects 
AMSA values. AMSA was superior to CPP as an indicator of return to a perfusing rhythm 
after defibrillation under condition of partial occlusion of the LAD coronary artery in a 
porcine model of cardiac arrest and resuscitation with partial LAD occlusion of 
approximately 75% of the internal lumen was maintained during CPR [96]  .During chest 
compression, CPP increased and exceeded threshold value for successful resuscitation. 
AMSA however, was signicantly lower in animals in which partial occlusion of the LAD was 
maintained during CPR. This was reflected in the greater number of electrical shocks 
required prior to terminating VF and in the lesser success of resuscitation. CPP is, in fact, 
an indirect indicator of myocardial flow produced by chest compression and represents a 
gradient pressure between aorta and right atrium. This gradient might be maintained even 
in the presence of occlusion of the coronary tree. AMSA, which is instead related to 
myocardial blood flow and metabolism, has been shown to be capable to substantially 
decrease when myocardial perfusion is reduced.                                                       
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Accordingly, the quality of chest compression is a major issue [25–27]. 
Effectiveness of chest compressions relates to compression depth, rate and chest-wall 
decompression [97]. Outcomes may have been improved by assuring adequate 
compression depth in addition to more optimal rates of compression [98, 99]. As chest 
compression is usually performed without feedback, and because relatively small changes 
in compression depth profoundly alter haemodynamic effectiveness and outcomes, there 
is an increasingly recognised need for a monitor of effectiveness of chest compression 
[100–102]. Li and colleagues [103] therefore investigated the possibility of assessing CPR 
quality, especially of chest compression depth, using AMSA – which has the important 
advantage of being noninvasive and calculable from the universally available ECG – as 
part of the current practices of advanced life support. In a porcine model of VF and CPR, 
animals were randomised to optimal or suboptimal chest compression after VF onset. 
Optimal mechanical compression depth was defined as a decrease of 25% in anterior–
posterior chest diameter during compression. Suboptimal compression in six animals was 
defined as a decrease of 17.5% in anterior–posterior chest diameter. All animals  had 
ROSC after optimal compression. This contrasted suboptimal compressions after which no 
animal had ROSC. As with CPP and end tidal CO2, AMSA once again has been proven to 
be predictive of outcomes. Calculated AMSA values during CPR and immediately prior to 
defibrillation attempts were signicantly greater after optimal chest compression:  the quality 
of chest compression was closely related to AMSA value and, in turn, to the likelihood of 
ROSC. As with the CPP threshold value, AMSA threshold value was achieved contingent 
upon compression depth such that AMSA increased progressively during chest 
compression and, as with CPP, predicted the likelihood of successful defibrillation. AMSA 
therefore was confirmed to serve as a guide to the effectiveness of chest compression and 
optimal timing of an electrical shock. AMSA measurement is therefore valuable to guide 
chest compression quality due to its capability to aid in restoring the electrical robustness 
of the myocardium through restoring threshold levels of coronary blood flow, as reflected 
by CPP. When the area under the VF amplitude spectrum curve is of insufficient 
magnitude, the rescuer is prompted to push harder and perhaps faster. 
Current American Heart Association (AHA) guidelines suggest an interval of 
chest compression prior to defibrillation if the duration of untreated cardiac arrest is >4 min 
[104]. However in case of unwitnessed cardiac arrest, downtime is not predictable. 
Ristagno et al therefore hypothesized and subsequently confirmed AMSA efficacy in 
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identifying the duration of untreated cardiac arrest [105]. In nine domestic male pigs, VF 
was induced and untreated for 15 min. AMSA, more so than VF amplitude and mean 
frequency, was highly correlated with VF downtime and decreased over the time. 
Significantly lower AMSA was observed after 3 min of untreated VF. Following the 4th min, 
AMSA values decreased more rapidly. AMSA therefore emerged as a tool able to predict 
the downtime of untreated cardiac arrest and thereby a guide to better initial intervention. 
  
Applicability of AMSA to the Clinical Scenario 
 
The subsequent step in the evolution of AMSA as a better indicator of 
intervention effectiveness and defibrillation guide was confirmation of its efficacy in clinical 
settings.  At present, in fact, chest compression creates artifacts on the ECG signal to the 
degree that pauses in CPR are mandatory for rhythm analysis prior to attempted de 
brillation [106, 107]. Substantial interruptions of chest compression have detrimental 
effects on the success of cardiopulmonary resuscitation [28, 84, 107], reducing the 
likelihood of successful defibrillation due to immediate declines in coronary perfusion [13, 
84, 108]. Bisera and co-workers retrospectively applied the AMSA algorithm to human 
ECG recordings obtained from AEDs (automatic external defibrillators) employed in out-of-
hospital cardiac arrests. The first confirmation of the capability of AMSA to predict 
successful defibrillation and ROSC in the clinical scenario was reported in late 2004 by 
Young et al. [109], and those results were recently confirmed by Ristagno et al [110]. 
The first study was a retrospective analysis by Young et al. [109] of ECG records 
of lead-2-equivalent recordings on 108 defibrillation attempts with an automated external 
defibrillator on 46 patients with out-of-hospital VF-related cardiac arrest. There was an 
impressive separation between AMSA values and successful VF conversion with ROSC. 
An AMSA value of 13 mV-Hz predicted successful defibrillation with a sensitivity of 91% 
and a specificity of 94%. This was the first evidence that the predictive value of AMSA 
developed in experimental models of cardiac arrest and resuscitation in pigs could be 
extended to humans. 
In 2008, the same Authors [110] analysed a new database that included 
episodes of VF or ventricular tachycardia with defibrillation attempts on humans who 
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experienced out-of-hospital cardiac arrest. ECGs were recorded from AEDs that provided 
escalating biphasic shock in the sequence 120, 150, 200 j. AMSA was confirmed as a 
valid tool for predicting the likelihood that any one electrical shock would restore a 
perfusing rhythm during cardiopulmonary resuscitation in 90 men with out-of-hospital 
cardiac arrest. The analysis was performed on a 4.1-s interval of ECG recordings 
immediately preceding the delivery of defibrillatory shock. For that study, the outcome was 
defined as being successful if defibrillation restored an organised rhythm with heart rate > 
40 bpm commencing within the 1-min postshock period and persisted for a minimum of 30 
s. The outcome was considered unsuccessful if VF, ventricular tachycardia (heart rate 
>150 bpm), asystole or pulseless electrical activity with pauses >5 s occurred. AMSA 
values were significantly greater in successful versus unsuccessful defibrillation (16 mV-
Hz and 7 mV-Hz, respectively; p < 0.0001). A threshold value of 12 mV-Hz AMSA was 
predictive of the success of each defibrillation attempt with a sensitivity of 91% and a 
specificity of 97% (Fig. C).  PPV, which refers to the proportion of shocks that correctly 
predicted perfusing rhythm restoration, was 95%. NPV, which refers to the proportion of 
shocks that predicted failure and actually failed to restore a perfusing rhythm, was 97%. 
The results of that study were consistent with the previous retrospective analysis [108,109] 
of human cardiac arrest patients. A very close AMSA threshold value was calculated and a 
high sensitivity and specificity of this approach was confirmed. Of particular interest  was 
that although defibrillators by different manufactures were employed in the two studies, 
results were consistent. This is therefore further confirmation that AMSA represents an 
excellent predictor of success of an electrical shock attempt, and this capability is 
independent of the defibrillatory energies and waveforms used. Although several 
limitations were clarified by the authors of those studies, such as the potential confounding 
variables of “hands-off time before defibrillation” that was not controlled for, and the old  
“three-shocks” protocol employed during that period, clinical  efficacy of AMSA was 
confirmed. 
Finally, in a study of 267 CPR sequences from 77 patients with out-of-hospital 
cardiac arrest, Eftestøl and colleagues [111] confirmed AMSA as one of the most powerful 
predictors of defibrillation success. 
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Fig. C Logistic regression representing amplitude spectrum area (AMSA) in relationship 
to defibrillation outcome  
Summary   
CPP and etCO2 represent useful tools for monitoring the effectiveness of chest 
compression and predicting CPR success. These measurements, however, are not 
feasible in out of-hospital cardiac arrest situations. Investigators therefore focused their 
attention on VF waveform morphology as a success predictor of resuscitation. Greater VF 
amplitude with dominant and median frequency was associated with improved outcomes. 
However, the challenge is to ensure high sensitivity and specificity, especially during 
precordial compression, to identify the ideal moment to deliver the defibrillatory shock. 
AMSA analysis represents an accurate predictor for successful defibrillation and is a 
simple parameter that can be easily obtained by a conventional surface ECG, which is part 
of routine practice of advanced cardiac life support. Moreover, this method has the 
potential advantage in that it is not invalidated by artefacts produced by chest compression 
and thereby can be used during CPR without detrimental interruptions of chest 
compression and ventilation. Experimentally, consistent evidence of AMSA validity has 
been proved in data from both animals and humans. Accordingly, AMSA has now 
emerged as a clinically applicable method derived from ECG tracing that may provide a 
real-time indicator for chest compression efficacy and predict defibrillation success. We 
therefore anticipate that the AMSA algorithm incorporated into conventional AEDs will 
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minimise interruption in chest compression and thus decrease the delivery of futile and 
detrimental electrical shocks, leading to more optimal defibrillation timing. 
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   AIM     OF   THIS   STUDY 
 
The present study is the first phase of large translational clinical study. It is based 
on the retrospective analysis of ECG and clinical data obtained from out-of-hospital 
cardiac arrest (OHCA) victims in the  Lombardy Region to evaluate and confirm the 
efficacy of AMSA as a predictor of successful defibrillation (DF) during CPR and calculate 
a threshold value for AMSA in this specific population.  The following phase will be 
observational and prospective, based on a similar patient population, aiming to validate 
on-field the efficacy and accuracy of AMSA as a guide to RCP in OHCA. At present, 
prospective clinical study are still lacking. 
In this phase, the following specific primary objectives will be addressed: 
 To verify the relationship between pre-DF AMSA values and success of defibrillation 
 To identify the threshold AMSA value capable to predict successful DF in first, 
second and subsequent defibrillation attempts 
 To evaluate the correlations between successful DF and other classical ROSC 
predictor derived from ECG recording, as amplitude and rate of VF and ventricular 
tachycardia (VT) 
 To evaluate the correlation between pre-DF AMSA value ,and vital hospital 
admission 
 
       EXPERIMENTAL   DESIGN 
     
 
Inclusion   criteria  
 The study has been designed to enroll 1000 adult patients with non-traumatic 
OHCA  in whom an ECG requiring defibrillation during CPR had been recorded.  The 
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recruitment period ranged from January, 1st , 2008 to Dec 31st,2009. On-field emergency 
interventions by automatic external defibrillators (AED) were carried out by ambulance 
emergency teams of the 118 network of Regione Lombardia, based in the provinces of 
Bergamo, Brescia, Como, Cremona, Lecco, Lodi, Milano, Monza, Mantova, Pavia, Sondrio 
and Varese. 
Exclusion  criteria  
Patients less than 18 years of age, pregnant, with traumatic OHCA or known advanced 
end-stage condition were excluded. Moreover, cases with inappropriate AED DF as 
identified by the core lab investigator (i.e. the author of the present manuscript) were 
excluded. 
Data collection 
AED stored electrograms and clinical data, which had been already stored in digital 
form at all operative units headquaters, were subsequently transmitted to the central 
database  collecting center (Institute of Anesthesiology of the S. Gerardo Hospital, Monza) 
and subsequently sent to the Mario Negri Institute, Milan, for verification of 
inclusion/exclusion criteria and subsequent AMSA analysis. 
AMSA  analysis 
AED electrograms were processed via a custom-made software based on Matlab 7.2. 
ECG signal was filtered in a window between 2 and 48 Hz in order to minimize low-
frequency artifacts from chest compressions and exclude environmental electrical 
interferences at frequencies > 48 Hz. Analogic ECG signals were then digitized and 
converted from time to frequency domain by the fast Fourier transform technique which 
converts a time-related voltage variation (mV) into a frequency-related voltage variation 
(Hz). The resultant relationship is called “power spectrum” or amplitude/frequency 
spectrum. The sum of individual amplitudes and frequencies determines AMSA = ∑Ai∙Fi  
where Ai is the amplitude relative to Frequency i. 
 A 2 sec ECG window ending at 0.5 sec before DF was analyzed and AMSA 
calculated, after fast Fourier transformation. In the 2 sec interval the classical waveform 
parameters were calculated, i.e. amplitude in mV and frequency in Hz. The dominant 
amplitude has been defined as the longest distance between two VF deflections; the mean 
amplitude as the average amplitude within the time interval. The mean and dominant 
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frequencies were obtained by the fast Fourier transform of the ECG signal: the mean 
frequency is the frequency value by which the spectrum is divided in two equal sectors, the 
dominant frequency is the one indicating the highest value of the power spectrum. 
DF was defined as successful in the presence of spontaneous rhythm ≥ 40 bpm starting 
within 60 secs from the DF. DF was defined as unsuccessful if, after DF , VF, ventricular 
tachycardia > 150 bpm,  asystole or pulseless electrical activity < 40 bpm were observed.  
 
Statistical  analysis 
 Threshold values of AMSA able to discriminate DF outcome were individuated and 
sensitivity, specificity, accuracy, positive and negative predictive values (PPV, NPV) were 
calculated.  AMSA value was defined as the one correlated to the best balance between 
sensibility and specificity  The area under the receiver operating characteristic (ROC) 
curve was measured: the area under the curve, as identified by sensibility and by the 
reciprocal of specificity for any variation of AMSA value, indicates the ability of AMSA in 
discriminating positive or negative results of DF: the discriminatory capability of the test is 
higher when area under the curve shifts towards 1, worse when it shifts towards 0.5 
  
  
     RESULTS 
Electrocardiographic (ECG) data recorded by automated external defibrillators from 
different manufactures (Zoll, PhysioControl) were obtained from 8.419 cardiac arrest 
events. Zoll defibrillators were provided with accelerometers for the discrimination between 
electrograms and chest compression artifacts.   Among these events, only VF/VT cardiac 
arrests receiving DFs were selected (n = 1055, 12,5%).  Of such 1055 patients, 583 were 
males and 472 females, of mean age 68.4+12.3. Clinical data previous to the index event, 
beyond those considered exclusion criteria, were  unknown or largely insufficient in more 
than 60% of cases and   were therefore excluded from the present analysis. 
 A total of 2.442 quality DF events, including 1055 first attempts and 1.387 subsequent 
ones, from 1.055 out-of-hospital cardiac arrests were included in the analyses.  The 
remaining 7364 were events of pulseless electrical activity, asystole, bradyarrhythmias for 
which the automated system did not indicate DF. No more than 8 inappropriate indications 
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and subsequent  DF discharges were delivered, 3 in patients with implanted pacemaker, 
the other as a result of erroneous  AED interpretation of spontaneous, not chest 
compression generated, artifacts.  An AED solid memory  recording with successful DF is 
reproduced in Fig.1, a filtered electrogram for AMSA processing in Fig 2  .    A sample of  
resulting AMSA profile of VF in a case with successful DF is showewd in Fig.3.  
Consensus decision on electrogram vs artifactual nature of the recording was required in 
1% of recordings, whereas consensus  interpretation of the recorded arrhythmia was 
carried out in 18 cases.  DF success rate was of 26%, 27%, and 25.2% for all, first, and 
subsequent DFs, respectively. AMSA was significantly greater prior to successful DFs, 
compared to that preceding unsuccessful ones (13.8 vs. 6.9 mV-Hz, and 13.9 vs. 6.8 mV-
Hz, and 13.7 vs. 7 mV-Hz, for all, first, and subsequent DFs respectively (Figure 4). 
Intersection of sensitivity, specificity and accuracy curves identified a threshold value of 
AMSA of approximately 9.5 mV-Hz, able to predict DF outcome, with a balanced 
sensitivity, specificity and accuracy of 80%, for all, first, and subsequent DFs (Figure 5). 
Moreover, intersection of PPV and accuracy curves identified a threshold value of AMSA 
of approximately 15 mV-Hz able to predict a successful DF with a PPV and accuracy of 
80%, for all, first, and subsequent DF attempts. AMSA values greater than 27 mV-Hz 
correctly predicted the success of DF with a PPV value of 100%. AMSA below 8 mV-Hz 
correctly predicted the DF failure with a NPV of > 95%, for all, first, and subsequent DFs. 
Further decreases in AMSA values below 4 mV-Hz achieved a NPV of 100%. Area under 
ROC curves was 0.872, 0.869, and 0.875 for all, first, and subsequent DFs, respectively 
(Figure 6). 
AMSA prediction of successful DF and ROSC was verified in a subgroup of 628 
patients with confirmed CPR outcome and hospital admission.  Of them 205 (33%) were 
declared dead on site, 177 (28%) died during transport to hospital, 105 (17%) died in 
emergency room and 141 (22%) were resuscitated.  AMSA mean value of resuscitated 
versus dead patients was significantly higher (11.93 + 5.65 vs 7.15 + 4.57, p < 0.05) (Fig 
7). The non significant differences with the mean AMSA values observed general 
population  probably reflect the differences in event number. 
 
 
    DISCUSSION 
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The present study was carried-out on a database the dimensions of which exceed 
those of the previously published studies, thanks to a design aimed to incorporate events 
and DF intervention in a densely populated area, Lombardy, with 10 million inhabitants. 
For this reason, raw data included all events which were initially declared of cardiac arrest 
on-field but a large proportion of them was probably of non cardiac origin. This explains 
the low proportion of cases (12,5%)  in which VF or VT amenable to DF was recorded, 
even taking into account the fact that asystole and bradyarrhythmias form a consistent or 
even prevalent finding in primary cardiac arrest [90].  This study confirms the AED as a 
reliable and effective devices to deliver appropriate and timely DF minimizing the chest 
compression standstill to confirm underlying cardiac rhythm [81]. 
AMSA values were comparable to those of previous studies[105-109]: its position in 
the superior portion of the values obtained by others reflects the   magnitude of the    
database, which entailed VF morphologies with extremely variable power-spectrum 
features;  it is however noteworthy that  only a 1,2 Hz  difference was found between the 
mean threshold value (13.8 Hz) and the threshold of 15 Hz  identifying 80% of successful 
DF attempts. The 13,8 Hz threshold value consistently approaches the 13 Hz value 
obtained in the first clinical study by Young [109]. This confirms that the power spectrum 
area widely included between 12-15 Hz, as it emerges from ours and other published data, 
consistently correlates with a perfused and  viable state of the fibrillating heart which 
allows to predict successful DF.  The presence of a small number of cases in which VT or 
ventricular flutter  instead of VF was recorded can explain a somewhat higher threshold 
value: in fact, their morphologies are characterized by discrete and tall electrograms 
amenable to higher AMSA values. On the other hand, 8 Hz has been confirmed as a 
reliable threshold below which DF attempts should be withheld.  
Of note is the fact that no difference was noted when recordings from devices 
provided with accelerometers to discriminate compression artifacts and from those not 
provided were compared: this confirms the reliability in the filtering settings of AMSA cutoff 
setup in accepting only signals of true cardiac origin, as demonstrated in previous 
experimental and clinical studies [112]. 
The  comparative analysis of AMSA values and inherent ROCs demonstrated no 
significant differences between the first and the subsequent DF in comparison with the 
unsuccessful DF.  This result is consistent with the fact that the perfusion and metabolic 
state is substantially comparable both when a single or multiple DF are needed to restore 
ROSC. Details of this subanalysis demonstrate that in most cases of multiple DF leading 
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to stable ROSC, recurrent VF after a variable period of ROSC and not persisting VF after a 
first of multiple DF is the case; so, electrical instability, even in the presence of restored 
perfusion is responsible for the need of multiple interventions as confirmed by the 
reproducibility of AMSA findings in the recurrent VF electrograms.  This findings  that the 
2005 ILS guidelines raccomendations for “one single shock only”, in order to avoid  
damage to the heart before other interventions do not apply to cases with better metabolic 
and perfusion profile where subsequent DF can achieve restoration of a perfusing rhythm 
[110]. 
The findings obtained by comparing AMSA values in patients successfully 
resuscitated versus those of patients who died either on-field or during transport to the 
hospital and in the emergency room (11.93 + 5.65 vs 7.15 + 4.57, p < 0.05) consistently 
confirm the clinical relevance of this parameter not only as an immediate predictor of 
successful DF but also as an reliable prognostic indicator, at least at short term. 
 
 
Study limitations 
Given the experimental design, in which the amplitude of the database and the “real 
life” setup were preferred to precise clinical data acquisition , this study has some obvious 
limitations: baseline clinical condition of the patients is largely unknown; time from cardiac 
arrest to beginning of CPR is unknown, although AMSA values can help to discriminate 
non-intervention time intervals longer than 10 minutes. Viceversa, as underlying conditions 
where largely unknown AMSA profile discriminations between ischemic and nonischemic 
VF was impossible [81]. Moreover, the modality and quality of CPR was not assessed but, 
given the number of cases, of rescue teams involved and operational settings, it is 
presumable that it was variable; however, this could be a minor problem as all rescue 
teams were part of the 118 network and were declared proficient after an adequate and 
generally adopted training  workup [100,101]. More importantly, the “hands off period” 
before DF was not taken into account [84], but its value should not be overestimated  as 
the use of AED has been demonstrated to minimize this period [111]. However, some 
variability should be taken into account when considering the number of delivered DF in 
each patient which were decided individually decided by the paramedic in charge of the 
defibrillator and/or by the rescue team leader.  the interruption of DF treatment after one or 
two failed attempts could have eliminated some theoretical possibility on successful DF 
and, therefore, of augmenting the positive case percentage and, consequently, modifying 
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the AMSA values. The same apply to the decision of early transport or on-site attempt to 
stabilize the clinical conditions which could have affected the outcome of the substudy 
population the fate of which has been analysed and compared with AMSA values. 
 
 
              CONCLUSIONS 
  
 In this population, probably the largest studied to date, an AMSA algorithm was capable to 
predict DF outcome with high accuracy, thus confirming previous experimental findings 
and results of smaller clinical studies.  Although these database deserves further insights 
and analyses, its positive results opens the way to a prospective study utilizing customized 
defibrillators incorporating a real-time display. If, it is reasonable to expect, also this study 
will be successful, a new generation of AMSA guided AED could be expected for approved 
clinical use in the next few years. 
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Fig.  1.  Automatic external defibrillation solid memory recording of a ventricular 
fibrillation event successfully interrupted by DC-shock and followed    by   
resumption  of sinus rhythm with ST elevation 
 
 
Fig.2 Filtered electrogram at 4 to 48Hz of a ventricular fibillation episode for AMSA 
analysis 
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Fig. 3  Typical AMSA profile of ventricular fibrillation in a successful 
defibrillation  event 
 
 
 
 
 
 
                        A       B          C                
Fig. 4  AMSA values in successful and failed defibrillation in all treated events (panel 
A),first (panel B) and subsequent defibrillation attempts. The difference between 
successful and failed attempts remain stable even after subdivision 
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  A        B                                                   C   
Fig. 5.  Intersection of sensitivity, specificity and accuracy curves of threshold value of 
AMSA for all, first, and subsequent defibrillation attempts (panels A,B,C): a threshold of 
approximately 9.5 mV-Hz, able to predict DF outcome, with a balanced sensitivity, 
specificity and accuracy of 80%. No significant differences appeared when first and 
subsequent attempts were considered separately. 
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   A      B      C 
Fig.  6 Area under ROC curves    for all, first, and subsequent defibrillations, respectively 
(panels A,B,C) did not show significant differences between total, first and subsequent 
successful attempt 
 38 
 
 
 
 
 
 
 
 
 
 
 Fig.  7.  AMSA value and intersection curves in a subgroup of events with confirmed 
CPR outcome  showing significant differences between dead and resuscitated 
patients (p = <0.05) 
 
 
 
 
 
